CD4+ T cell help in cancer immunology and immunotherapy

By J. Borst, T. Ahrends, Nikolina Bąbała, C. Melief, W. Kastenmüller. Nature reviews. Immunology, 2018

1,343 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/0fefced2ead5f0af03b2daf64081c1dbab090525

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Kondrashova
2. E. Richardson
3. H. Toh
4. E. Williams
5. Andrew Bradley
6. J. Pearson
7. N. Waddell
8. R. Tay

Citations in the corpus

• Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms (2020, background): “These tumourinfiltrating Tregs consisted of a FoxP3hi population suppression-competent population, and a second poorly suppressive FoxP3lo population that was induced by the TH1-polarising cytokine IL-12 and that also secreted the pro-inflammatory cytokines IFNγ and IL-17 [65].”
• Deep learning in cancer diagnosis, prognosis and treatment selection (2021, background): “Infiltrating immune cell populations, such as CD4+ and CD8+ T cells, are potential important biomarkers of immunotherapy response [139, 140].”